Literature DB >> 1024824

Why do Tc-99m chelates work for cholescintigraphy?

G Firnau.   

Abstract

There are four structural requirements for substances that are excreted by the liver: 1. Their molecular weight is between 300 and 1,000. 2. They are organic anions. 3. They contain at least two ring systems in the molecule. 4. They are bound to serum albumin. All the Tc-99m chelates suggested for cholescintigraphy fulfill these requirements. For the first time a rational for their efficacy is provided.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1024824     DOI: 10.1007/BF00257959

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  9 in total

1.  THE INFLUENCE OF ENTEROHEPATIC CIRCULATION ON TOXICITY OF DRUGS.

Authors:  R T WILLIAMS; P MILLBURN; R L SMITH
Journal:  Ann N Y Acad Sci       Date:  1965-03-12       Impact factor: 5.691

2.  The intrahepatic conjugation of sulfobromophthalein and glutathione in the dog.

Authors:  N B JAVITT; H O WHEELER; K J BAKER; O L RAMOS; S E BRADLEY
Journal:  J Clin Invest       Date:  1960-10       Impact factor: 14.808

3.  Metabolism of tetracycline in the rat and the dog.

Authors:  R G KELLY; D A BUYSKE
Journal:  J Pharmacol Exp Ther       Date:  1960-10       Impact factor: 4.030

4.  Mechanisms of bile secretion.

Authors:  R W BRAUER
Journal:  J Am Med Assoc       Date:  1959-03-28

5.  Technetium 99m-pyridoxylideneglutamate: a new hepatobiliary radiopharmaceutical. I. Experimental aspects.

Authors:  R J Baker; J C Bellen; P M Ronai
Journal:  J Nucl Med       Date:  1975-08       Impact factor: 10.057

6.  A 99mTc-labeled replacement for 131-I-rose bengal in liver and biliary tract studies.

Authors:  T H Lin; A Khentigan; H S Winchell
Journal:  J Nucl Med       Date:  1974-07       Impact factor: 10.057

7.  123I-iodo-bromsulphalein as a liver and biliary scanning agent.

Authors:  M L Goris
Journal:  J Nucl Med       Date:  1973-11       Impact factor: 10.057

8.  99MTc-tetracycline as a kidney and gallbladder imaging agent.

Authors:  C P Fliegel; M K Dewanjee; L B Holman; M A Davis; S Treves
Journal:  Radiology       Date:  1974-02       Impact factor: 11.105

9.  Technetium-99m-pyridoxylideneglutamate: a new hepatobiliary radiopharmaceutical. II. Clinical aspects.

Authors:  P M Ronai; R J Baker; J C Bellen; P J Collins; P J Anderson; H Lander
Journal:  J Nucl Med       Date:  1975-08       Impact factor: 10.057

  9 in total
  5 in total

1.  What does protein binding of radiopharmaceuticals mean exactly?

Authors:  O Jeghers; A Piepsz; H R Ham
Journal:  Eur J Nucl Med       Date:  1990

2.  The hepatic excretion of 131I-rose bengal and 99mTc-IDA derivatives in Rotor's syndrome.

Authors:  G Galli; C Focacci; C L Maini; M Salvatori; L Troncone; G L Fedeli; G L Rapaccini
Journal:  Eur J Nucl Med       Date:  1982

3.  99mTc-diethyl-HIDA: a contribution to the study of its structure.

Authors:  U Fonda; B Pedersen
Journal:  Eur J Nucl Med       Date:  1978-04-01

Review 4.  Role of 99mTc-IDA cholescintigraphy in evaluating biliary tract disorders.

Authors:  H S Weissmann; M S Frank; R Rosenblatt; L A Sugarman; L M Freeman
Journal:  Gastrointest Radiol       Date:  1980-08-15

5.  The plasma protein binding of HIDA.

Authors:  R W Nicholson; K J Herman; R A Shields; H J Testa
Journal:  Eur J Nucl Med       Date:  1980-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.